Annual SG&A
$116.66 M
-$3.29 M-2.75%
31 December 2023
Summary:
Heron Therapeutics annual selling, general & administrative expenses is currently $116.66 million, with the most recent change of -$3.29 million (-2.75%) on 31 December 2023. During the last 3 years, it has risen by +$10.58 million (+9.97%). HRTX annual SG&A is now -8.62% below its all-time high of $127.66 million, reached on 31 December 2019.HRTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$23.34 M
-$4.17 M-15.17%
30 September 2024
Summary:
Heron Therapeutics quarterly selling, general & administrative expenses is currently $23.34 million, with the most recent change of -$4.17 million (-15.17%) on 30 September 2024. Over the past year, it has dropped by -$5.53 million (-19.14%). HRTX quarterly SG&A is now -42.78% below its all-time high of $40.80 million, reached on 30 June 2023.HRTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$7.66 B
-$27.97 M-0.37%
30 September 2024
Summary:
Heron Therapeutics TTM selling, general & administrative expenses is currently -$7.66 billion, with the most recent change of -$27.97 million (-0.37%) on 30 September 2024. Over the past year, it has dropped by -$7.79 billion (-5841.75%). HRTX TTM SG&A is now -78836.64% below its all-time high of $135.48 million, reached on 31 March 2022.HRTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.8% | -19.1% | -5841.8% |
| 3 y3 years | +10.0% | -33.3% | -6427.3% |
| 5 y5 years | +24.3% | -8.7% | -6173.9% |
HRTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -8.4% | +10.0% | -42.8% | +133.4% | -29.7% | at low |
| 5 y | 5 years | -8.6% | +24.3% | -42.8% | +133.4% | -83.8% | at low |
| alltime | all time | -8.6% | +4566.3% | -42.8% | +3435.0% | <-9999.0% | at low |
Heron Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $23.34 M(-15.2%) | $87.28 M(-6.0%) |
| June 2024 | - | $27.52 M(+4.2%) | $92.81 M(-12.5%) |
| Mar 2024 | - | $26.42 M(+164.1%) | $106.08 M(-9.1%) |
| Dec 2023 | $116.66 M(-2.7%) | $10.00 M(-65.4%) | $116.66 M(-12.5%) |
| Sept 2023 | - | $28.87 M(-29.2%) | $133.35 M(+0.5%) |
| June 2023 | - | $40.80 M(+10.3%) | $132.66 M(+7.0%) |
| Mar 2023 | - | $36.99 M(+38.5%) | $123.98 M(+3.4%) |
| Dec 2022 | $119.95 M(-5.8%) | $26.70 M(-5.2%) | $119.95 M(-6.0%) |
| Sept 2022 | - | $28.18 M(-12.3%) | $127.63 M(-5.1%) |
| June 2022 | - | $32.12 M(-2.5%) | $134.44 M(-0.8%) |
| Mar 2022 | - | $32.95 M(-4.1%) | $135.48 M(+6.4%) |
| Dec 2021 | $127.33 M(+20.0%) | $34.37 M(-1.8%) | $127.33 M(+5.2%) |
| Sept 2021 | - | $34.99 M(+5.5%) | $121.01 M(+12.0%) |
| June 2021 | - | $33.16 M(+33.6%) | $108.02 M(+7.7%) |
| Mar 2021 | - | $24.81 M(-11.6%) | $100.27 M(-5.5%) |
| Dec 2020 | $106.08 M(-16.9%) | $28.06 M(+27.5%) | $106.08 M(-2.1%) |
| Sept 2020 | - | $22.00 M(-13.4%) | $108.32 M(-3.2%) |
| June 2020 | - | $25.41 M(-17.0%) | $111.89 M(-6.7%) |
| Mar 2020 | - | $30.62 M(+1.1%) | $119.91 M(-6.1%) |
| Dec 2019 | $127.66 M(+36.0%) | $30.29 M(+18.5%) | $127.66 M(+1.3%) |
| Sept 2019 | - | $25.57 M(-23.5%) | $126.06 M(+1.6%) |
| June 2019 | - | $33.42 M(-12.9%) | $124.06 M(+11.4%) |
| Mar 2019 | - | $38.37 M(+33.7%) | $111.37 M(+18.6%) |
| Dec 2018 | $93.87 M(+14.3%) | $28.70 M(+21.7%) | $93.87 M(+6.6%) |
| Sept 2018 | - | $23.57 M(+13.6%) | $88.02 M(+4.2%) |
| June 2018 | - | $20.74 M(-0.6%) | $84.44 M(-0.3%) |
| Mar 2018 | - | $20.86 M(-8.7%) | $84.66 M(+3.0%) |
| Dec 2017 | $82.16 M(+19.0%) | $22.85 M(+14.3%) | $82.16 M(+5.5%) |
| Sept 2017 | - | $19.99 M(-4.6%) | $77.85 M(+3.3%) |
| June 2017 | - | $20.95 M(+14.1%) | $75.35 M(+7.4%) |
| Mar 2017 | - | $18.36 M(-1.0%) | $70.17 M(+1.7%) |
| Dec 2016 | $69.03 M(+93.1%) | $18.54 M(+6.0%) | $69.03 M(+5.7%) |
| Sept 2016 | - | $17.49 M(+10.8%) | $65.29 M(+16.5%) |
| June 2016 | - | $15.78 M(-8.4%) | $56.05 M(+19.0%) |
| Mar 2016 | - | $17.22 M(+16.4%) | $47.11 M(+31.8%) |
| Dec 2015 | $35.74 M(+81.2%) | $14.80 M(+79.4%) | $35.74 M(+36.2%) |
| Sept 2015 | - | $8.25 M(+20.6%) | $26.25 M(+18.1%) |
| June 2015 | - | $6.84 M(+16.8%) | $22.22 M(+11.7%) |
| Mar 2015 | - | $5.86 M(+10.5%) | $19.89 M(+0.8%) |
| Dec 2014 | $19.73 M(-10.1%) | $5.30 M(+25.5%) | $19.73 M(-0.9%) |
| Sept 2014 | - | $4.22 M(-6.4%) | $19.91 M(-10.1%) |
| June 2014 | - | $4.51 M(-20.8%) | $22.13 M(+0.5%) |
| Mar 2014 | - | $5.69 M(+4.0%) | $22.02 M(+0.4%) |
| Dec 2013 | $21.94 M(+153.4%) | $5.48 M(-15.1%) | $21.94 M(+10.0%) |
| Sept 2013 | - | $6.45 M(+46.4%) | $19.94 M(+25.3%) |
| June 2013 | - | $4.40 M(-21.5%) | $15.92 M(+24.1%) |
| Mar 2013 | - | $5.61 M(+61.4%) | $12.83 M(+48.2%) |
| Dec 2012 | $8.66 M(+147.3%) | $3.48 M(+43.2%) | $8.66 M(+34.3%) |
| Sept 2012 | - | $2.43 M(+84.9%) | $6.44 M(+24.5%) |
| June 2012 | - | $1.31 M(-8.8%) | $5.18 M(+18.4%) |
| Mar 2012 | - | $1.44 M(+14.0%) | $4.37 M(+24.9%) |
| Dec 2011 | $3.50 M(-11.8%) | $1.26 M(+8.9%) | $3.50 M(+32.2%) |
| Sept 2011 | - | $1.16 M(+127.9%) | $2.65 M(+37.0%) |
| June 2011 | - | $509.00 K(-10.5%) | $1.93 M(-48.6%) |
| Mar 2011 | - | $569.00 K(+38.8%) | $3.76 M(-5.3%) |
| Dec 2010 | $3.97 M(+7.1%) | $410.00 K(-7.9%) | $3.97 M(-9.0%) |
| Sept 2010 | - | $445.00 K(-80.9%) | $4.36 M(-9.7%) |
| June 2010 | - | $2.33 M(+199.0%) | $4.83 M(+35.6%) |
| Mar 2010 | - | $781.00 K(-2.6%) | $3.56 M(-3.9%) |
| Dec 2009 | $3.71 M(-13.9%) | $802.00 K(-12.1%) | $3.71 M(-7.3%) |
| Sept 2009 | - | $912.00 K(-14.4%) | $4.00 M(-8.3%) |
| June 2009 | - | $1.07 M(+15.0%) | $4.36 M(+4.9%) |
| Mar 2009 | - | $927.00 K(-15.1%) | $4.15 M(-3.6%) |
| Dec 2008 | $4.31 M(-8.0%) | $1.09 M(-14.2%) | $4.31 M(-16.3%) |
| Sept 2008 | - | $1.27 M(+47.4%) | $5.14 M(+11.0%) |
| June 2008 | - | $863.00 K(-20.1%) | $4.63 M(-0.2%) |
| Mar 2008 | - | $1.08 M(-44.0%) | $4.64 M(-0.8%) |
| Dec 2007 | $4.68 M(+29.0%) | $1.93 M(+153.0%) | $4.68 M(+27.0%) |
| Sept 2007 | - | $762.00 K(-12.6%) | $3.69 M(-1.8%) |
| June 2007 | - | $872.00 K(-22.0%) | $3.75 M(-1.6%) |
| Mar 2007 | - | $1.12 M(+19.8%) | $3.81 M(+5.1%) |
| Dec 2006 | $3.63 M | $933.00 K(+12.4%) | $3.63 M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2006 | - | $830.00 K(-11.0%) | $3.72 M(-1.0%) |
| June 2006 | - | $933.00 K(+0.1%) | $3.76 M(+3.0%) |
| Mar 2006 | - | $932.00 K(-9.1%) | $3.65 M(+2.3%) |
| Dec 2005 | $3.56 M(+10.5%) | $1.02 M(+18.1%) | $3.56 M(+7.9%) |
| Sept 2005 | - | $868.00 K(+5.5%) | $3.31 M(-0.8%) |
| June 2005 | - | $823.00 K(-3.1%) | $3.33 M(+0.1%) |
| Mar 2005 | - | $849.00 K(+11.0%) | $3.33 M(+3.2%) |
| Dec 2004 | $3.23 M(+15.2%) | $765.00 K(-14.4%) | $3.23 M(+5.2%) |
| Sept 2004 | - | $894.00 K(+9.0%) | $3.07 M(+8.7%) |
| June 2004 | - | $820.00 K(+9.9%) | $2.82 M(+2.0%) |
| Mar 2004 | - | $746.00 K(+22.9%) | $2.77 M(-1.1%) |
| Dec 2003 | $2.80 M(-7.4%) | $607.00 K(-6.5%) | $2.80 M(+6.1%) |
| Sept 2003 | - | $649.00 K(-15.3%) | $2.64 M(-5.5%) |
| June 2003 | - | $766.00 K(-1.5%) | $2.79 M(-5.8%) |
| Mar 2003 | - | $778.00 K(+74.0%) | $2.97 M(+0.6%) |
| Dec 2002 | $3.02 M(-6.9%) | $447.00 K(-44.4%) | $2.95 M(-9.1%) |
| Sept 2002 | - | $804.00 K(-14.2%) | $3.24 M(-0.7%) |
| June 2002 | - | $937.00 K(+23.3%) | $3.27 M(+2.3%) |
| Mar 2002 | - | $760.00 K(+2.2%) | $3.19 M(-1.6%) |
| Dec 2001 | $3.25 M(-6.2%) | $743.30 K(-10.0%) | $3.25 M(-5.2%) |
| Sept 2001 | - | $826.20 K(-4.5%) | $3.43 M(-1.3%) |
| June 2001 | - | $864.80 K(+6.4%) | $3.47 M(-1.0%) |
| Mar 2001 | - | $812.80 K(-11.9%) | $3.51 M(+1.3%) |
| Dec 2000 | $3.46 M(+1.9%) | $923.10 K(+5.9%) | $3.46 M(+1.5%) |
| Sept 2000 | - | $871.60 K(-3.2%) | $3.41 M(+0.0%) |
| June 2000 | - | $900.30 K(+17.2%) | $3.41 M(-17.0%) |
| Mar 2000 | - | $768.00 K(-12.1%) | $4.11 M(-16.8%) |
| Dec 1999 | $3.40 M(+36.0%) | $873.30 K(+0.4%) | $4.94 M(+46.7%) |
| Sept 1999 | - | $870.00 K(-45.6%) | $3.37 M(-15.8%) |
| June 1999 | - | $1.60 M(0.0%) | $4.00 M(0.0%) |
| Mar 1999 | - | $1.60 M(-328.6%) | $4.00 M(0.0%) |
| Dec 1998 | $2.50 M(-66.2%) | -$700.00 K(-146.7%) | $4.00 M(-37.5%) |
| Sept 1998 | - | $1.50 M(-6.3%) | $6.40 M(-3.0%) |
| June 1998 | - | $1.60 M(0.0%) | $6.60 M(-5.7%) |
| Mar 1998 | - | $1.60 M(-5.9%) | $7.00 M(-5.4%) |
| Dec 1997 | $7.40 M(-54.9%) | $1.70 M(0.0%) | $7.40 M(-43.5%) |
| Sept 1997 | - | $1.70 M(-15.0%) | $13.10 M(-9.7%) |
| June 1997 | - | $2.00 M(0.0%) | $14.50 M(-7.6%) |
| Mar 1997 | - | $2.00 M(-73.0%) | $15.70 M(-4.3%) |
| Dec 1996 | $16.40 M(+70.8%) | $7.40 M(+138.7%) | $16.40 M(+40.2%) |
| Sept 1996 | - | $3.10 M(-3.1%) | $11.70 M(+6.4%) |
| June 1996 | - | $3.20 M(+18.5%) | $11.00 M(+7.8%) |
| Mar 1996 | - | $2.70 M(0.0%) | $10.20 M(+6.3%) |
| Dec 1995 | $9.60 M(+12.9%) | $2.70 M(+12.5%) | $9.60 M(+4.3%) |
| Sept 1995 | - | $2.40 M(0.0%) | $9.20 M(+5.7%) |
| June 1995 | - | $2.40 M(+14.3%) | $8.70 M(+2.4%) |
| Mar 1995 | - | $2.10 M(-8.7%) | $8.50 M(-1.2%) |
| Dec 1994 | $8.50 M(-51.4%) | $2.30 M(+21.1%) | $8.60 M(-22.5%) |
| Sept 1994 | - | $1.90 M(-13.6%) | $11.10 M(-17.2%) |
| June 1994 | - | $2.20 M(0.0%) | $13.40 M(-14.6%) |
| Mar 1994 | - | $2.20 M(-54.2%) | $15.70 M(-5.4%) |
| Dec 1993 | $17.50 M(+98.9%) | $4.80 M(+14.3%) | $16.60 M(+16.9%) |
| Sept 1993 | - | $4.20 M(-6.7%) | $14.20 M(+18.3%) |
| June 1993 | - | $4.50 M(+45.2%) | $12.00 M(+22.4%) |
| Mar 1993 | - | $3.10 M(+29.2%) | $9.80 M(+11.4%) |
| Dec 1992 | $8.80 M(+79.6%) | $2.40 M(+20.0%) | $8.80 M(+15.8%) |
| Sept 1992 | - | $2.00 M(-13.0%) | $7.60 M(+11.8%) |
| June 1992 | - | $2.30 M(+9.5%) | $6.80 M(+15.3%) |
| Mar 1992 | - | $2.10 M(+75.0%) | $5.90 M(+18.0%) |
| Dec 1991 | $4.90 M(-3.9%) | $1.20 M(0.0%) | $5.00 M(-2.0%) |
| Sept 1991 | - | $1.20 M(-14.3%) | $5.10 M(-1.9%) |
| June 1991 | - | $1.40 M(+16.7%) | $5.20 M(0.0%) |
| Mar 1991 | - | $1.20 M(-7.7%) | $5.20 M(+2.0%) |
| Dec 1990 | $5.10 M(-23.9%) | $1.30 M(0.0%) | $5.10 M(-1.9%) |
| Sept 1990 | - | $1.30 M(-7.1%) | $5.20 M(0.0%) |
| June 1990 | - | $1.40 M(+27.3%) | $5.20 M(-13.3%) |
| Mar 1990 | - | $1.10 M(-21.4%) | $6.00 M(+22.4%) |
| Dec 1989 | $6.70 M(-2.9%) | $1.40 M(+7.7%) | $4.90 M(+40.0%) |
| Sept 1989 | - | $1.30 M(-40.9%) | $3.50 M(+59.1%) |
| June 1989 | - | $2.20 M | $2.20 M |
| Dec 1988 | $6.90 M(+53.3%) | - | - |
| Dec 1987 | $4.50 M | - | - |
FAQ
- What is Heron Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Heron Therapeutics?
- What is Heron Therapeutics annual SG&A year-on-year change?
- What is Heron Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Heron Therapeutics?
- What is Heron Therapeutics quarterly SG&A year-on-year change?
- What is Heron Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Heron Therapeutics?
- What is Heron Therapeutics TTM SG&A year-on-year change?
What is Heron Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of HRTX is $116.66 M
What is the all time high annual SG&A for Heron Therapeutics?
Heron Therapeutics all-time high annual selling, general & administrative expenses is $127.66 M
What is Heron Therapeutics annual SG&A year-on-year change?
Over the past year, HRTX annual selling, general & administrative expenses has changed by -$3.29 M (-2.75%)
What is Heron Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of HRTX is $23.34 M
What is the all time high quarterly SG&A for Heron Therapeutics?
Heron Therapeutics all-time high quarterly selling, general & administrative expenses is $40.80 M
What is Heron Therapeutics quarterly SG&A year-on-year change?
Over the past year, HRTX quarterly selling, general & administrative expenses has changed by -$5.53 M (-19.14%)
What is Heron Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of HRTX is -$7.66 B
What is the all time high TTM SG&A for Heron Therapeutics?
Heron Therapeutics all-time high TTM selling, general & administrative expenses is $135.48 M
What is Heron Therapeutics TTM SG&A year-on-year change?
Over the past year, HRTX TTM selling, general & administrative expenses has changed by -$7.79 B (-5841.75%)